Open access
Open access
Powered by Google Translator Translator

All Posts

Systematic review: Border controls, restricted entry, quarantine essential for curbing COVID-19 and future pandemics.

1 Jul, 2021 | 09:53h | UTC

News release: Border controls, restricted entry, quarantine essential for curbing COVID-19 and future pandemics – British Medical Journal

Original study: Lessons from countries implementing find, test, trace, isolation and support policies in the rapid response of the COVID-19 pandemic: a systematic review – BMJ Open

Commentary: Strategies ID’d Than Can Interrupt Spread of Infectious Disease – HealthDay

 


RCT: Similar outcomes with 5 vs. 2 years of zoledronate treatment following adjuvant chemotherapy in early breast cancer.

1 Jul, 2021 | 09:50h | UTC

Outcomes With 5 vs 2 Years of Zoledronate Treatment Following Adjuvant Chemotherapy in Early Breast Cancer – The ASCO Post

Original Study: Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)

 


Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 Jul, 2021 | 09:44h | UTC

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up – Annals of Oncology

 

Commentary on Twitter

 


AHA Scientific Statement: Evidence-based practices in the cardiac catheterization laboratory.

1 Jul, 2021 | 09:47h | UTC

Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association – Circulation

 


Perspective | Why no one is sure if Delta is deadlier – “The variants are spreading faster, but they don’t necessarily have incentive to kill more often”.

1 Jul, 2021 | 09:52h | UTC

Why No One Is Sure If Delta Is Deadlier – The Atlantic

 


AHA Scientific Statement: Managing atrial fibrillation in patients with heart failure and reduced ejection fraction.

1 Jul, 2021 | 09:46h | UTC

Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association – Circulation: Arrhythmia and Electrophysiology

Commentary: The Chicken or the Egg – Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: Importance of Early AF Treatment – American Heart Association

Top Things to Know: Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction

 

Commentary on Twitter

 


M-A: Simultaneous use of hypertonic saline and IV furosemide for fluid overload – “Benefits of the HSS+Fx over Fx were observed across all examined outcomes in acute decompensated heart failure patients with fluid overload”.

1 Jul, 2021 | 09:41h | UTC

Simultaneous Use of Hypertonic Saline and IV Furosemide for Fluid Overload: A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)

 


Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms.

30 Jun, 2021 | 10:24h | UTC

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms – Frontiers in Microbiology

 


Case Series: Myocarditis following immunization with mRNA COVID-19 vaccines.

30 Jun, 2021 | 10:22h | UTC

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military – JAMA Cardiology

See also: Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination – JAMA Cardiology

Editorials: Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines AND Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working

Commentary: More Evidence Links Myocarditis to mRNA COVID-19 Vaccines – TCTMD

Related: CDC: mRNA vaccines are likely linked to cases of myocarditis and pericarditis – 1,226 cases of myocarditis or pericarditis have been reported mostly in people under 30.

 

Commentary on Twitter

 


Systematic Review: Cilostazol for intermittent claudication – “Cilostazol has been shown to improve walking distance in people with intermittent claudication. However, participants taking cilostazol had higher odds of experiencing headache”.

1 Jul, 2021 | 09:42h | UTC

Cilostazol for intermittent claudication – Cochrane Library

Summary: Cilostazol for peripheral arterial disease – Cochrane Library

 


Exclusive-WHO estimates COVID-19 boosters needed yearly for most vulnerable.

30 Jun, 2021 | 10:17h | UTC

Exclusive-WHO estimates COVID-19 boosters needed yearly for most vulnerable – Reuters

Related: CDC group says there isn’t enough data yet to recommend Covid booster shots – CNBC

 


Covid: Masks upgrade cuts infection risk, research finds.

30 Jun, 2021 | 10:16h | UTC

Covid: Masks upgrade cuts infection risk, research finds – BBC

 


COVID-19 cut Brazilian life span almost 2 years in 2021.

30 Jun, 2021 | 10:19h | UTC

COVID-19 cut Brazilian life span almost 2 years in 2021 – CIDRAP

Original Study: Reduction in life expectancy in Brazil after COVID-19 – Nature Medicine

 


Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.

30 Jun, 2021 | 10:13h | UTC

Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome – European Heart Journal

 


Consensus Statement: The role of lung ultrasound in COVID-19 disease.

30 Jun, 2021 | 10:12h | UTC

The role of lung ultrasound in COVID-19 disease – Insights into Imaging

 


RCT: Among patients with diarrhea-predominant irritable bowel syndrome, a low FODMAP diet achieved earlier symptomatic improvements in stool frequency and excessive wind.

30 Jun, 2021 | 10:09h | UTC

Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes – American Journal of Clinical Nutrition (link to abstract – $ for full-text)

 


Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta.

30 Jun, 2021 | 10:11h | UTC

Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta – The Conversation

Related: Effectiveness of COVID-19 vaccines against the B.1.617.2 variant – medRxiv

 


M-A: The utility of the rapid shallow breathing index in predicting successful extubation – “As a stand-alone test, the RSBI has moderate sensitivity and poor specificity for predicting extubation success”.

30 Jun, 2021 | 10:07h | UTC

The Utility of the Rapid Shallow Breathing Index in Predicting Successful Extubation: A Systematic Review and Meta-analysis – CHEST (link to abstract – $ for full-text)

 


Multidisciplinary guideline on Achilles tendinopathy.

30 Jun, 2021 | 10:06h | UTC

Dutch multidisciplinary guideline on Achilles tendinopathy – British Journal of Sports Medicine

 


M-A: SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure.

30 Jun, 2021 | 10:08h | UTC

SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis – EClinicalMedicine

 


Review: Virtual consultation for red eye.

30 Jun, 2021 | 10:04h | UTC

Virtual consultation for red eye – The BMJ

 

Commentary on Twitter

 


IHME COVID-19 model has been updated for over 200 world locations.

29 Jun, 2021 | 10:13h | UTC

COVID-19 Projections – Institute for Health Metrics and Evaluation

Video: Insights from IHME’s latest COVID-19 model update

 

Commentary on Twitter

 


Review: Imaging of inflammatory disease of the pancreas.

30 Jun, 2021 | 10:03h | UTC

Imaging of inflammatory disease of the pancreas – British Journal of Radiology

 


Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.

29 Jun, 2021 | 10:09h | UTC

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial – The Lancet Infectious Diseases

Invited commentary: COVID-19 vaccines for children younger than 12 years: are we ready? – The Lancet Infectious Diseases

 

Commentary on Twitter

 


SARS-CoV-2 mRNA vaccines induce persistent human germinal center responses, suggesting immunity will be long-lasting.

29 Jun, 2021 | 10:03h | UTC

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses – Nature

Commentaries: Immune response to FDA-approved vaccines is strong and potentially long-lasting – News Medical

Related: A long-term perspective on immunity to COVID – “Clinical studies now indicate that immunity will be long-lasting”.

 

Commentary on Twitter (thread – click for more)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.